Find Federal Grants
Emergency Award: Rapid Acceleration of Diagnostics Tribal Data Repository (RADx TDR) (U24 Clinical Trial Not Allowed)
National Institutes of Health · RFA-OD-22-011
Office of the Assistant Secretary for Health · PA-PHE-22-002
Increasing Immediate Engagement and Retention in HIV Treatment with Substance Users (R01- Clinical Trials Required)
National Institutes of Health · RFA-DA-23-002
A Community Research Resource: Characterization of the Resident Ocular Microbiome. (U24 Clinical Trial Not Allowed)
National Institutes of Health · RFA-EY-22-001
U.S. Mission to Jordan · PAS-JOR-FY22-003
Centers for Disease Control - NCCDPHP · CDC-RFA-DP22-2207
National Institutes of Health · PAR-22-154
Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional)
National Institutes of Health · RFA-CA-22-020
Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-OD-22-009
INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed)
National Institutes of Health · RFA-OD-22-007
SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)
National Institutes of Health · RFA-CA-22-025
Partnerships for the Development of Novel Therapeutics to Combat Select Antibiotic Resistant Bacteria and Fungi (R01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-AI-22-028
National Institutes of Health · RFA-CA-22-016
Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required)
National Institutes of Health · RFA-OD-22-010
National Institute of General Medical Sciences (NIGMS) Bridges to the Baccalaureate Research Training Program (T34)
National Institutes of Health · PAR-22-125
Development and Optimization of Next-Generation Immunological Assays to Support Influenza Clinical Studies and Trials (UH2/UH3 Clinical Trial Not Allowed)
National Institutes of Health · RFA-AI-22-020
National Institutes of Health · RFA-CA-22-016
NIDCD Research Opportunities for New Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
National Institutes of Health · RFA-DC-23-001
Centers for Disease Control - NCIPC · CDC-RFA-CE22-2204
STRENGTHENING COLLABORATION BETWEEN TB CONTROL PROGRAMS AND AFFILIATED PARTNERS IN THE UNITED STATES
Centers for Disease Control - NCHHSTP · CDC-RFA-PS22-2205